[Market Focus] Cosmax Rises 7% on Talks with MFDS to Strengthen K-Beauty Competitiveness

The share price of Cosmax is on the rise following discussions with the Ministry of Food and Drug Safety on global regulatory responses.

As of 9:40 a.m. on March 20, 2026, Cosmax was trading at 191,700 won, up 12,500 won (6.98%) from the previous trading day.

The previous day, Cosmax held a meeting at the R&I Center in Pangyo, Seongnam, Gyeonggi Province, with stakeholders including Ahn Youngjin, Director of the Biopharmaceutical and Herbal Medicine Bureau at the Ministry of Food and Drug Safety. Both sides discussed strategies to respond to the introduction of in vitro testing methods for sunscreens. Cosmax became the first company in Korea to introduce automated testing equipment capable of measuring in vitro SPF and PA for sunscreens.

This content was produced with the assistance of AI translation services.